Epsilon Healthcare Limited

EPN

AU0000137598

Pharmaceuticals

Delayed Australian S.E. Other stock markets 06:37:33 2023-12-17 pm EST			5-day change	1st Jan Change
0.024 ^AUD	-.--%		-.--%	-.--%

Jul. 08	Epsilon Healthcare Limited Announces Termination of Xiao Cui as Company Secretary	CI
Jul. 04	Epsilon Healthcare Comes Out of Voluntary Administration	MT

Epsilon Healthcare Announces Change of Company Address

July 03, 2024 at 11:39 pm EDT

Epsilon Healthcare announced that effective from 4 July 2024 the Company's Registered Office and Principal Place of business will be changed to Level 1, 1 Jamison Street Sydney NSW 2000.

Latest news about Epsilon Healthcare Limited

Epsilon Healthcare Limited Announces Termination of Xiao Cui as Company Secretary	Jul. 08	CI
Epsilon Healthcare Comes Out of Voluntary Administration	Jul. 04	MT
Epsilon Healthcare Announces Change of Company Address	Jul. 03	CI
Epsilon Healthcare Administrators Revert Control to Directors as DOCA Executed	Jun. 26	MT
Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	Dec. 19	CI
Epsilon Healthcare Limited Issues a Notice of Cancellation of Extraordinary General Meeting	Dec. 19	CI
Epsilon Healthcare Appoints Joint and Several Administrators	Dec. 18	MT
Epsilon Healthcare Limited Provides Information to Shareholders	Dec. 14	CI
Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd	Nov. 30	CI
Epsilon Healthcare Limited Announces Board Appointments	Nov. 30	CI
Epsilon Healthcare Provides Information to Shareholders	Nov. 22	CI
Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer	Nov. 21	CI
Epsilon Healthcare Issues Notice of Extraordinary General Meeting	Nov. 20	CI
Epsilon Healthcare Limited Announces Change of Address, Effective 22 November 2023	Nov. 20	CI
Epsilon Healthcare Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-31	CI
Epsilon Healthcare Rebrands Manufacturing, Telehealth Businesses	23-08-03	MT
Epsilon Healthcare Appoints CEO	23-05-18	MT
Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023	23-05-18	CI
Healthcare, IT Rally Ends Australian Shares' Three-Day Losing Streak	23-05-12	MT
Epsilon Healthcare Jumps 25% After Subsidiary Renews Medicinal Cannabis Permit	23-05-12	MT
Epsilon Healthcare Limited Auditor Raises 'Going Concern' Doubt	23-03-30	CI
Epsilon Healthcare Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-02-27	CI
Epsilon Healthcare Limited Announces Executive Changes	22-12-23	CI
Epsilon Healthcare Limited Announces Company Secretary Changes	22-11-30	CI
Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer	22-11-30	CI

Chart Epsilon Healthcare Limited

Duration

Period

More charts

Epsilon Healthcare Limited is an Australia-based global healthcare and pharmaceuticals company. The Company has a diversified and vertically integrated portfolio of assets, including healthcare and pharmaceutical contract development and manufacturing. The Companyâs segments include the manufacture and distribution of hydroponics equipment, materials and nutrients, and the development and delivery of medicinal cannabis. The Company owns medicinal cannabis assets, including the GMP cannabis manufacturing facility in the Southern Hemisphere (the Southport Facility) in Southport, Australia, and the Tetra Health clinic group. The Company also provides advisory services related to medicinal cannabis. The Companyâs subsidiaries include Dragon Vision Limited, Canndeo Pty Ltd, Canna Clinics Pty Ltd, THC Pharma Pty Ltd, Metra Holdings Pty Ltd, Tetra Pty Ltd, Medimar Pty Ltd and Demimar Pty Ltd.

Sector

Pharmaceuticals

Calendar

2024-08-28 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
EPSILON HEALTHCARE LIMITED	-.--%	4.88M
ELI LILLY AND COMPANY	+60.25%	841B
NOVO NORDISK A/S	+38.56%	625B
JOHNSON & JOHNSON	-4.49%	360B
MERCK & CO., INC.	+18.30%	327B
ABBVIE INC.	+9.64%	300B
ASTRAZENECA PLC	+14.15%	242B
ROCHE HOLDING AG	+3.11%	228B
NOVARTIS AG	+16.98%	227B
AMGEN INC.	+12.87%	174B